Eiko LifeSciences has completed acquisition of 25.01% stake in the equity share capital of Reflux Pharmaceuticals (RPPL) at a consideration of Rs 7.008 crore. Pursuant to the said acquisition, RPPL has become an Associate Company of Eiko Lifesciences.
The said acquisition of stake in RPPL would benefit the Company in its long-term strategic growth plan to diversify its portfolio and set its footprints in various Geographic areas. The company will also be preferred source of supply for some of the key raw materials to RPPL and help them in sourcing key Active Pharma Ingredients (APIs) which help them in its manufacturing process, along with it both companies will co-develop and market new products to strengthen its global network.
Eiko LifeSciences is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and Globally.
| Company Name | CMP |
|---|---|
| BASF India | 3865.25 |
| Tata Chemicals | 761.95 |
| SRF | 2793.80 |
| Pidilite Inds. | 1437.80 |
| Deepak Nitrite | 1858.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: